Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Genfit S.A. ADR (GNFT)

Genfit S.A. ADR (GNFT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 175,776
  • Shares Outstanding, K 45,775
  • Annual Sales, $ 8,860 K
  • Annual Income, $ -115,620 K
  • 60-Month Beta 1.24
  • Price/Sales 19.11
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade GNFT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.51 +9.40%
on 08/25/21
4.49 -14.48%
on 08/31/21
+0.03 (+0.79%)
since 08/24/21
3-Month
3.50 +9.71%
on 07/19/21
4.49 -14.48%
on 08/31/21
-0.07 (-1.79%)
since 06/24/21
52-Week
3.50 +9.71%
on 07/19/21
7.19 -46.59%
on 02/10/21
+0.17 (+4.63%)
since 09/24/20

Most Recent Stories

More News
GENFIT: June 30, 2021 Annual Shareholders Meeting results

June 30, 2021 -- GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and chronic liver diseases, today announced the results...

GNFTF : 3.7100 (-6.08%)
GNFT : 3.84 (+3.78%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Genfit SA and Encourages Investors with Losses of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Genfit SA ("Genfit" or "the Company") (NASDAQ: GNFT) for violations...

GNFTF : 3.7100 (-6.08%)
GNFT : 3.84 (+3.78%)
Shareholder Alert: Robbins LLP Announces That Genfit SA (GNFT) is Being Sued for Misleading Shareholders

Shareholder rights law firm Robbins LLP announces that a purchaser of Genfit SA American Depository Shares (NASDAQ: GNFT) filed a class action complaint against the Company and its officers and directors...

GNFTF : 3.7100 (-6.08%)
GNFT : 3.84 (+3.78%)
The Law Offices of Frank R. Cruz Announces Investigation of Genfit S.A. (GNFT) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Genfit S.A. ("Genfit" or the "Company") (NASDAQ: GNFT) on behalf of investors concerning the Company's possible violations of federal securities...

GNFTF : 3.7100 (-6.08%)
GNFT : 3.84 (+3.78%)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Genfit S.A. (GNFT) on Behalf of Investors

Law Offices of Howard G. Smith announces an investigation on behalf of Genfit S.A. ("Genfit" or the "Company") (NASDAQ: GNFT) investors concerning the Company's possible violations of federal securities...

GNFTF : 3.7100 (-6.08%)
GNFT : 3.84 (+3.78%)
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Genfit S.A. (GNFT) on Behalf of Investors

Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Genfit S.A. ("Genfit" or the "Company") (NASDAQ:...

GNFTF : 3.7100 (-6.08%)
GNFT : 3.84 (+3.78%)
Genfit SA to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / September 30, 2020 / Genfit SA (NASDAQ:GNFT) will be discussing their earnings results in their 2020 First Half Earnings call to be held on September 30, 2020 at 4:30 PM Eastern...

GNFTF : 3.7100 (-6.08%)
GNFT : 3.84 (+3.78%)
Intercept (ICPT) Posts New Positive Results on NASH Drug

Intercept (ICPT) releases new favorable outcome on OCA from the REGENERATE study, which evaluated patients with liver fibrosis due to NASH.

VKTX : 6.48 (-0.92%)
GLMD : 3.05 (+0.33%)
ICPT : 16.06 (-1.71%)
GNFT : 3.84 (+3.78%)
Intercept's (ICPT) Q2 Earnings and Revenues Beat Estimates

Intercept (ICPT) reports better-than-expected results for the second quarter of 2020.

VKTX : 6.48 (-0.92%)
GLMD : 3.05 (+0.33%)
ICPT : 16.06 (-1.71%)
GNFT : 3.84 (+3.78%)
Is Genfit (GNFT) Stock a Solid Choice Right Now

Genfit (GNFT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

GNFT : 3.84 (+3.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Genfit SA is a biopharmaceutical company. It focuses on the discovery and development of therapeutic and diagnostic solutions in metabolic and liver related diseases. The company's lead products include Elafibranor, Nitazoxanide and TGFTX1 which are in clinical stage. Genfit SA is based in Loos, France....

See More

Key Turning Points

3rd Resistance Point 4.10
2nd Resistance Point 3.99
1st Resistance Point 3.92
Last Price 3.84
1st Support Level 3.74
2nd Support Level 3.63
3rd Support Level 3.56

See More

52-Week High 7.19
Fibonacci 61.8% 5.78
Fibonacci 50% 5.35
Fibonacci 38.2% 4.91
Last Price 3.84
52-Week Low 3.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar